Methotrexate Revisited—in Recurrent Head and Neck Cancer
Aims Response of single agent chemotherapy in improving quality of life in patients with recurrent head and neck cancers. Methods and material This is a study of the 18 patients with advanced cancers of head and neck, who had failed earlier attempts of radical treatment with Surgery, Radiotherapy ±...
Main Authors: | R.P.S. Banipal, M.K. Mahajan |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2011-01-01
|
Series: | Palliative Care |
Online Access: | https://doi.org/10.4137/PCRT.S6107 |
Similar Items
-
Methotrexate Revisited—in Recurrent Head and Neck Cancer
by: R.P.S. Banipal, et al.
Published: (2011-05-01) -
Methotrexate, an attractive agent for palliation in head and neck cancers
by: Mukesh Sharma, et al.
Published: (2014-01-01) -
A pharmacokinetic study of methotrexate in advanced head and neck cancer
by: Stewart, A. L.
Published: (1980) -
Exosomes in head and neck cancer. Updating and revisiting
by: Samuel Rodríguez Zorrilla, et al.
Published: (2019-01-01) -
Recurrent and Metastatic Head and Neck Cancer: A Paradigm Shift?
by: Leonor Abreu Ribeiro, et al.
Published: (2020-09-01)